Pluristem Therapeutics Inc.
Data Safety Monitoring Board DSMB Approves Advancement to Intermediate Dose Level of PLX-PAD
Published in Blood Weekly, January 7th, 2010
"The advancement to the next dose level with Pluristem's placenta derived PLX-PAD is encouraging and we hope that the positive trend in clinical results derived from treating the first patients at the lower dose will continue," said Professor Dr. Andre Schmidt-Lucke, director of the Franziskus-Krankenhaus of Berlin and Project...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-01-07)
More Articles from Blood Weekly
- Anemia
New anemia study findings have been reported by scientists at University of Amsterdam, Medical Academy - BioTrends Research Group, Inc.
BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across a Variety of Physician Specialties - Celgene Corporation
Initial Data from CALGB-Led Study of Treatment with Continuous REVLIMID(R) in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant Reported - Children's Hospital Boston
Gene for Devastating Kidney Disease Discovered - Eisai
Results From Phase II Trial in Critical Care Medicine Showed Eritoran Tetrasodium E5564 To Be Well Tolerated in Patients with Severe Sepsis - FatsofLife.com
Omega-3s may Help Protect the Eyes and Kidneys Along With the Heart - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
